| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 101.96M | 150.70M | 71.18M | 63.69M | 76.97M | 79.40M |
| Gross Profit | 22.51M | 34.23M | 15.86M | 16.18M | 14.05M | 9.18M |
| EBITDA | -13.73M | 12.92M | 7.99M | -1.94M | -20.13M | -22.48M |
| Net Income | 12.04M | 7.61M | 6.83M | -1.44M | -22.38M | -26.62M |
Balance Sheet | ||||||
| Total Assets | 133.79M | 197.44M | 150.21M | 154.32M | 163.50M | 182.26M |
| Cash, Cash Equivalents and Short-Term Investments | 27.15M | 53.35M | 48.28M | 18.89M | 35.76M | 18.90M |
| Total Debt | 5.86M | 4.65M | 8.99M | 210.00K | 727.00K | 4.03M |
| Total Liabilities | 18.08M | 20.51M | 37.08M | 23.93M | 22.75M | 24.09M |
| Stockholders Equity | 115.71M | 176.93M | 113.13M | 130.40M | 140.75M | 158.17M |
Cash Flow | ||||||
| Free Cash Flow | 12.12M | -46.94M | 28.82M | -14.07M | 17.53M | -33.74M |
| Operating Cash Flow | 14.88M | -39.51M | 28.92M | -14.04M | 17.68M | -32.16M |
| Investing Cash Flow | -2.06M | -6.75M | 180.00K | -35.00K | -147.00K | -1.58M |
| Financing Cash Flow | -2.37M | 53.58M | 1.51M | -430.00K | -1.47M | 1.38M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | HK$491.03M | 5.56 | 11.22% | 10.37% | 14.24% | 3.63% | |
| ― | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
| ― | HK$622.27M | 74.60 | 5.25% | ― | 111.72% | 1.61% | |
| ― | $550.50M | -13.89 | -1.15% | ― | -41.44% | -209.76% | |
| ― | HK$702.50M | 35.26 | -51.81% | ― | -20.65% | -616.18% | |
| ― | HK$343.12M | 3.66 | 3.66% | 1.33% | -13.13% | 128.79% | |
| ― | $455.05M | ― | -0.25% | ― | 152.54% | 87.07% |
Artini Holdings Limited announced the successful passing of all resolutions at its Annual General Meeting held on September 29, 2025. The resolutions included the adoption of financial statements, re-election of directors, and the granting of mandates for share issuance and repurchase. This outcome reflects strong shareholder support and positions the company for continued operational stability and strategic flexibility.
The most recent analyst rating on (HK:0789) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Artini Holdings Limited stock, see the HK:0789 Stock Forecast page.
Artini Holdings Limited has entered into a strategic cooperation agreement with Guangzhou Baiyunshan Wei Yi Industries Co., Ltd. to jointly develop products in the big healthcare sector and expand into overseas markets. This collaboration aims to leverage Artini’s international market advantages and Baiyunshan Wei Yi’s technological and brand strengths to enhance Artini’s competitiveness and product portfolio, potentially opening new revenue streams.
The most recent analyst rating on (HK:0789) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Artini Holdings Limited stock, see the HK:0789 Stock Forecast page.
Artini Holdings Limited, a company incorporated in Bermuda, has issued a supplemental announcement regarding its annual report for the year ending March 31, 2024. The announcement provides additional information about the share options granted to ten consultants under the 2019 Share Option Scheme. A total of 71,000,000 share options were granted on July 15, 2020, with an exercise period that ended on July 14, 2023. This update does not affect any other information in the annual report.
The most recent analyst rating on (HK:0789) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Artini Holdings Limited stock, see the HK:0789 Stock Forecast page.
Artini Holdings Limited has announced its upcoming annual general meeting scheduled for September 29, 2025, in Hong Kong. Key agenda items include the adoption of financial statements, re-election of directors, and authorization of director remuneration. The meeting will also consider resolutions to empower directors to manage share allotments and related financial instruments, potentially impacting the company’s capital structure and shareholder value.